Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human mesencephalic astrocyte-derived neurotrophic factor

EU orphan designation number: EU/3/15/1486   
Active ingredient: Recombinant human mesencephalic astrocyte-derived neurotrophic factor
Indication: Treatment of retinitis pigmentosa
Sponsor: Regintel Limited
Templetown, Carlingford, County Louth, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/04/2015 Orphan designation EMA/OD/327/14 (2015)2950 of 24/04/2015
27/04/2016 Change of name and/or address of sponsor
08/09/2016 Transfer of orphan designation EMA/OD/327/14/T/01 (2016)5744 of 05/09/2016
22/11/2016 Transfer of orphan designation EMA/OD/327/14/T/02 (2016)7592 of 18/11/2016